Johnson & Johnson Starts New Late Stage COVID-19 Vaccine Trial

Published November 16, 2020 530 Views

Rumble Johnson & Johnson will study the potential benefits of a second dose.

BREAKING: Rumble to Combine with NASDAQ listed CFVI